Summary
Several tumors are characterized by elevated levels of polyamines involved in vital cell proliferation processes. Polyamine oxidases (PAO), present in ruminant and particularily in fetal calf serum (FCS), degrade polyamines to polyaminoaldehydes and other products that inhibit cell proliferation. Since most in vitro assays for cloning tumor stem cells use FCS as an essential supplement of the nutrient media, we examined the effects of specifically inhibiting the PAO activity on the clonal growth of leukemic cells and the following normal lymphocytes: the W 25 rat chloroleukemia, the M1 mouse myeloblastic and the L 1210 rat lymphoblastic leukemia, a primary human acute myeloblastic leukemia (AML) and acute lymphocytic leukemia (ALL) as well as normal human PHA-stimulated lymphocytes. In the presence od horse serum, nontoxic doses of the PAO inhibitor 1-hydroxybenzyloxyamine did not affect colony growth of either cell type. However, in the presence of FCS, clonal growth of W 25, ALL, AML, and PHA lymphocytes was significantly stimulated by the enzyme inhibitor. Our data suggest (a) that poor cell proliferation of several tumors in vitro may result from the reaction of polyamines (from cells) and PAO (from serum), (b) that this can be easily tested by means of a specific PAO inhibitor, and (c) that the growth conditions can be optimized by adding nontoxic doses of the enzyme inhibitor or by exchanging FCS for another serum.
Similar content being viewed by others
References
Allen JC, Smith CJ, Hussian JI, Thomas JM, Gaugas JM (1979) Inhibition of lymphocyte proliferation by polyamine requires ruminant plasma polyamine oxidase. Eur J Biochem 107:153–159
Boyum A (1968) Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21:Suppl 97
Courtnay VJ, Selby PJ, Smith IE, Mills J, Peckham MJ (1978) Growth of human tumor cells from biopsies using to soft agar techniques. Br J Cancer 38:77
Dresser H (1980) Polyamines as markers of malignancy in human leukemia and other haematological diseases. In: Gaugas IM (ed) Polyamines in biomedical research. John Wiley, Chichester New York Brisbane Toronto pp 415–435
Gaugas JM (1980) Biogenic diamines and polyamines in support and in inhibition of lymphocyte proliferation. In: Gaugas JM (ed) Polyamines in biomedical research, John Wiley, Chichester pp 343–362
Hamburger AW, Salmon SE (1977) Primary bio-assay of human tumor stem cells. Science 197:461–463
Higgins ML, Tillman MC, Rupp JP, Leach FR (1969) Effects of polyamines on cell culture cells. J Cell Physiol 74:149–154
Ichikawa J (1969) Differentiation of a cell line of myeloid leukemia. J Cell Physiol 74:223–234
Maschler R, Smith CJ, Allen JC, Maurer HR (1982) Elucidation of the different effects of polyamines and other naturally-occurring inhibitors of cell proliferation (chalones) on T-lymphocytes and granulocyte colony growth in vitro. Z Naturforsch 380:74–78
Maurer HR, Ali-Osman F (1981) Tumor stem cell cloning in agarcontaining capillaries. Naturwissenschaften 67:381
Maurer HR, Maschler R, Dietrich R, Goebel B (1977) In vitro culture of lymphocyte colonies in agar capillary tubes after PHA-stimulation. J Immunol Methods 8:353–364
Morgan DML (1980) Polyamine oxidases. In: Gaugas JM (ed) Polyamines in biomedical research. John Wiley, Chichester pp 285–302
Russel DH, Durie BGM (1978) Polyamines as biochemical markers of normal and malignant growth. Raven Press, New York (Progress in cancer research and therapy, Vol 8)
Shay H, Gruenstein M, Marx HE, Glazer L (1951) The development of lymphatic and myelogenous leukemia in Wistar rats following gastic instillation of methylcholanthrene. Cancer Res 11:29–35
Smith CJ, Maschler R, Maurer HR, Allen JC (1982) Inhibition of cells in culture by polyamines does not depend on the presence of ruminant serum. Cell Tissue Kinet (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ali-Osman, F., Maurer, H.R. Stimulation of clonal tumor cell growth in vitro by inhibiting the serum polyamine oxidase activity. J Cancer Res Clin Oncol 106, 17–20 (1983). https://doi.org/10.1007/BF00399892
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00399892